The natriuretic and diuretic efficacy of atriopeptidase inhibitors following intravenous and oral administration.
Shepperson
N B
NB
Discovery Biology, Pfizer Central Research, Sandwich, Kent.
Samuels
G M
GM
Barclay
P L
PL
Ellis
P
P
D000284:Administration, Oral; D000818:Animals; D003509:Cyclohexanecarboxylic Acids; D004231:Diuresis / Q000187:drug effects*; D006852:Hydrochlorothiazide / Q000494:pharmacology; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D009318:Natriuresis / Q000187:drug effects*; D015260:Neprilysin / Q000037:antagonists & inhibitors* / Q000494:pharmacology
D003509:Cyclohexanecarboxylic Acids; D006852:Hydrochlorothiazide; C060942:candoxatrilat; D015260:Neprilysin